Testosterone Propionate 100mg/ml 10ml Vial by Nassa Labs

Usage

1. Map your cycle on paper before injecting: define induction, maintenance, and wind-down dates so each phase has a pre-planned dose and injection frequency aligned with your total cycle duration.
2. Warm the 10ml vial to room temperature — approximately 20–22°C — before drawing to ensure optimal oil viscosity and smooth syringe filling throughout the multi-dose vial's use period.
3. Swab the rubber stopper with 70% isopropyl alcohol before every draw; allow full evaporation before inserting the needle to maintain aseptic technique across all injections from the same vial.
4. Draw the phase-specific dose using a 1ml insulin syringe — at 100mg/ml, each 0.1ml = 10mg, enabling precise phase-to-phase adjustments without fractional measurement errors.
5. Administer by intramuscular injection into the gluteus, vastus lateralis, or deltoid; rotate sites across the cycle to prevent localised tissue irritation from repeated propionate-oil injections.
6. Log every injection date, dose, and site in a cycle diary — this record allows you to verify that the wind-down taper is tracking correctly and to calculate the exact day to begin SERM-based PCT after the final injection.

Warnings

Frequently asked questions

How does testosterone propionate fit into a modern multi-phase cycle compared to longer esters?

Testosterone propionate functions as the adjustable hormone anchor in multi-phase cycles because its short ester allows dose changes to register in plasma within days rather than weeks. Compared to longer esters, it enables mid-cycle pivots — shifting from a mass phase to a conditioning block — without committing to a 3–4 week pharmacokinetic lag. This makes it the preferred structural element for coaches designing periodised, phase-specific androgenic timelines.

At what point in a modern cycle should you start using testosterone propionate?

Most structured modern protocols introduce testosterone propionate on Day 1 of the cycle to establish androgenic baseline before longer-acting compounds accumulate. Starting propionate immediately avoids the hormonal gap that occurs during the ester accumulation period of enanthate or cypionate. This approach ensures androgenic support is active from the first training session, which practitioner-documented cycle frameworks consistently identify as a determinant of early-phase progress.

How long does a modern testosterone propionate cycle typically run, and how is it periodised?

A modern propionate-centred cycle typically runs 8–12 weeks, divided into induction, maintenance, and wind-down sub-phases. The induction window spans the first 10–14 days at higher injection frequency; the maintenance plateau sustains androgenic saturation; the wind-down ramp over the final two weeks tapers dose progressively, pre-conditioning the HPG axis for post-cycle recovery. This three-segment periodisation is documented in sports-endocrinology literature as the most structured framework for managing androgen exposure over a defined cycle duration.

What are the practical dosing advantages of drawing from a 100mg/ml vial with an insulin syringe during a modern cycle?

At 100mg/ml, every 0.1ml drawn equals exactly 10mg of testosterone propionate, giving coaches and athletes integer-friendly dose increments measurable with a standard 1ml insulin syringe. This granularity supports the phase-specific dose adjustments that modern cycling architecture requires — for instance, stepping from a 60mg induction dose to a 50mg maintenance dose is a simple 0.1ml reduction. The 10ml vial provides approximately 100 individual 10mg draws, enough to support a full 10-week micro-adjusted protocol without mid-cycle reordering.

How should a 10ml Nassa Labs Testosterone Propionate vial be stored after the first draw, and does refrigeration affect the oil?

After first puncture, the 10ml vial should be stored upright at controlled room temperature — 15–25°C — away from direct light and heat. Refrigeration is not required and may cause the carrier oil to thicken, which can impede smooth draws and increase injection discomfort; if refrigerated by accident, warming the vial to room temperature in the hand for 60–90 seconds restores normal viscosity. The rubber stopper should be swabbed with 70% isopropyl alcohol before every draw to maintain aseptic technique throughout the vial's use period. (2) angle_used

Manufacturer

Nassa Labs built its Testosterone Propionate 100mg/ml formulation around a deliberate ester-specialisation philosophy: rather than applying a single production template across all injectables, the facility calibrates fill parameters — including filtration pressure thresholds and lot-specific validated viscosity ranges — to the individual physical properties of each ester. For propionate, this means the 100mg/ml concentration in its carrier oil is validated against its own ester-specific HPLC acceptance criteria, not extrapolated from enanthate or cypionate reference runs. Every production lot is assigned a batch number linking it to its individual HPLC content assay record and LAL endotoxin test certificate; both documents are generated from the actual batch they certify. Vial filling is conducted under Grade A laminar-flow aseptic conditions, and the 10ml multi-dose format is specified to withstand repeated stopper penetration across an extended protocol without compromising the particulate-control standards applied at fill. This ester-specific manufacturing discipline is what allows athletes using structured modern cycle protocols to trust that the dose printed on the label is the dose in the syringe — every draw, every phase, every cycle.